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Abstract
Peripheral intravenous (PIV) catheters are the most commonly used catheters in hospitals, with up to 70% of patients
requiring a peripheral venous line during their hospital stay. This represents 200 million PIV catheters used per year in
acute-care hospitals in the United States alone. These medical devices are also used in other health care settings, such as
long-term care facilities and nursing homes, and common indications include the administration of medications,
nutrients, and ﬂuids. These catheters require proper maintenance and care to avoid complications such as phlebitis,
inﬁltration, occlusion, local infection, and bloodstream infection. Recently it has been suggested that PIV catheter use
may lead to a higher rate of complications than previously thought. This is important because some studies have claimed
that the rate of bloodstream infections due to PIV catheters is actually comparable to the rates observed with central
venous catheters, rather than much lower as previously thought. Moreover, catheter-related infections are now seen as
largely preventable. Our goal was to review the current literature and provide an overview of the various approaches
used to manage PIV catheter sites as well as review current recommendations.
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arious parameters have an inﬂuence on possible catheter
complications, such as the type of catheter, the site ofV insertion, the skin preparation method used, the dressing
selected to cover the site, the securement method, the catheter
dwell time, the frequency of replacement, and the patient pop-
ulation studied. For example, a recent publication looked at
various parameters relevant to peripheral intravenous (PIV)
catheters and their inﬂuence on phlebitis.1 It is difﬁcult to
determine the contribution of each of those parameters when
complications occur, and it is beyond the scope of this article
to cover all these factors or try to determine their relative
importance. Our focus is on the dressings used to cover PIV
catheters and their role in preventing infection. Figure 1respondence concerning this article should be addressed to
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j JAVA j Vol 19 No 4 j 20illustrates examples of different dressing approaches for PIV
access sites, from lowest to highest cost (ie, only considering
unit cost and not overall cost of treatment). With each unit
cost increase, additional features of the product increase bene-
ﬁts for the care of PIV catheter insertion sites.
How common are PIV catheters?
A variety of different catheters are used in hospitals and PIV
catheters are the most frequently used.2,3 A larger body of liter-
ature exists on the complications associated with central venous
catheters because they are perceived as being more invasive and
more likely to have serious complications. Recently, more atten-
tion has been given to PIV catheters because the frequency of
their use is higher, and they are also more likely to be inserted
in emergency situations where it is not always possible to follow
a strict protocol. Therefore the rate of complications for these de-
vices has been hypothesized to be higher than previously
thought,4-6 or at least signiﬁcant in absolute numbers of patients
affected given the large numbers of patients who receive them.7
This becomes even more important in light of the many reports
suggesting overuse of these devices, especially in emergency de-
partments where the insertion is likely to be a routine procedure
at admission and done in conditions that are often not optimal14
Figure 1. Examples of dressings for peripheral intravenous access sites. (A) Gauze and tape. (B)
Transparent film dressing. (C) Bordered transparent film dressing. (D) Bordered transparent film dressing
with chlorhexidine gluconate gel patch.  3M 2013, 2014. All rights reserved.given the urgency of the situation. Pujol et al4 published a study
showing that the number of bloodstream infections (BSIs)
caused by PIV catheters and central venous catheters was
similar, and that PIV catheters inserted in the emergency depart-
ment caused the highest number of episodes. Abbas et al8 found
in a small study (106 patients, 86 with PIV catheter insertion)
that 49% of the PIV catheters inserted at emergency department
admission were never used. Guidance from epic39 includes
removing these devices as soon as they are no longer needed.
How often is infection a problem?
Hospital-acquired BSIs are important causes of complica-
tions and mortality in the United States, and the proportion
due to antibiotic-resistant organisms is increasing in US hospi-
tals. This information was reported through a surveillance
study involving 24,179 infections observed over a period of
7.5 years in 49 participating hospitals.10 Intravascular devices
were the most frequent predisposing factor for BSIs, and half
of cases occurred in a critical-care setting. The authors further
estimated that there may be >10,000 PIV catheter-related
Staphylococcus aureus bacteremia infections in hospitalized
adults in the US each year.10 In addition to the pain and
discomfort experienced by patients, the added costs of BSIs
to the health care system are signiﬁcant.11
Infection in PIV catheter sites is believed to occur mainly
from normal skin ﬂora bacteria migrating into the puncture
wound made at the time of insertion.12,13 Staphylococcus epi-
dermidis has been reported to account for approximately 70%
of catheter-related infections.14-16 Other authors have cited
Staphylococcus aureus as the main cause of infection,4 or at
least as another signiﬁcant contributor.5 Therefore, the skin
disinfection method used before the insertion of a catheter
and the type of dressing used to cover the site and protect it
from outside organisms have signiﬁcant inﬂuences on the
risk of infection. For skin disinfection, chlorhexidine gluconate
has recently been found to be superior to povidone-iodine and
octenidine in a clinical trial involving 57 patients and
measuring catheter-related colonization and sepsis.17 This is
reﬂected in current guidelines from the Infusion Nurses Soci-
ety, which advocates the preferred use of chlorhexidine gluco-
nate for skin preparation, except in infants younger than age 2
months.18 For dressings, if using gauze and tape, the gauze
used should be sterile and the tape should be from a sealed2014packet. It is important to note that although gauze may be ster-
ile coming out of its package, it does not provide a waterproof
barrier and over time it can get contaminated and will need to
be changed more often. Partially used surgical tape rolls that
have been open for undetermined amounts of time have been
found to be frequently contaminated with bacteria, including
multidrug-resistant organisms.19 The frequency of dressing
change is also a factor to consider: Dressings deﬁnitely need
to be changed if soiled or damaged, but if still intact, changing
a dressing may contribute to introducing contamination. A
recent study20 demonstrated that clinically indicated replace-
ment of PIV catheters instead of routine replacement was
adequate and did not lead to increased complications. The
topic of clinically indicated catheter replacement was consid-
ered an unresolved issue in the 2011 Centers for Disease Con-
trol and Prevention guidelines,13 but the ﬁndings of a 2012
study20 have been incorporated into the recent 2014 epic3
guidelines.9 A clear implication of reducing the frequency at
which PIV catheters are changed is that the dressings used
need to effectively hold on longer than when catheters were
changed every 48-96 hours. Transparent ﬁlms allow visual in-
spection of an insertion site and can typically be changed less
frequently than gauze and tape, and they are therefore favored
in the new epic3 guidelines.9
The implementation of an evidence-based educational pro-
gram and a deﬁned protocol can successfully reduce PIV
catheter-related complications in a hospital setting. Fakih
et al21 described improvements in PIV catheter care after
the implementation of an educational program in a 804-bed
tertiary-care teaching hospital in Michigan and provided infor-
mation on infection rates before and after the intervention.
They reported a preintervention rate of PIV catheter-
associated BSI of 2.2 cases per 10,000 patient-days, and a
postintervention rate of 0.44 cases per 10,000 patient-days,
which represented a statistically signiﬁcant improvement
(P ¼ .016). This study21 included 4,434 PIV catheters over a
period of about 1 year and the authors concluded that enforc-
ing compliance to guidelines is key to reducing PIV catheter-
related infections, and this is possible through an educational
intervention paired with an evaluation of performance.
Although their study did not focus speciﬁcally on dressings
but on documentation of PIV catheter duration and scrubbing
the hub, all aspects of PIV catheter care are important to reducej Vol 19 No 4 j JAVA j 257
infection and their work highlights that indeed, these infections
are preventable.
Various studies22-24 have compared different dressings in an
attempt to determine which is best to prevent infection at the
site of the catheter and BSI. Research on this topic started in the
1980s, shortly after transparent ﬁlms entered themarket, and typi-
cally compared them with gauze, which was then the standard of
care. The observation thatﬂuid could sometimes pool under trans-
parent ﬁlms was the reason clinicians wondered if this new prod-
uct could create a higher risk of infection. The early studies had
several limitations for various reasons. Sometimes the treatments
being compared were not changed at the same frequency, or
topical antiseptic ointments were used more often in conjunction
with gauze than with transparent ﬁlms. Some studies looked at
catheter tip colonization, others at skin colonization, and BSI
data was not necessarily collected. Various brands of transparent
ﬁlms were used in different studies and may not have been equiv-
alent in their performance. Consequently, results were mixed and
questions remained regarding the infection rate obtained with
transparent ﬁlms vs gauze and tape.
More recent studies on this topic have helped evolve our un-
derstanding of the role of dressings in protecting the site from
infection. Madeo et al23 point out that all transparent ﬁlms may
not be equivalent because they can differ in their moisture va-
por transmission rate (MVTR). Their study23 compared gauze
and tape dressings with a transparent ﬁlm for dressing perfor-
mance and found that the dressing condition was signiﬁcantly
better for the transparent ﬁlm over the 72 hours of their study.
The issue of the MVTR has also been discussed by other au-
thors. This measurement is obtained in a laboratory situation
and does not take into account clinically important factors
such as how well the adhesive adheres to the skin, how long
it maintains its adhesion, and how gentle it is when the dres-
sing is removed. In fact, even in a laboratory assay, results
from Lin et al25 showed that the temperature and relative hu-
midity can greatly affect MVTR and some commercially avail-
able transparent ﬁlms were comparable to gauze for this
parameter when tested in vitro. In general gauze had a higher
MVTR than transparent ﬁlms, except at very high humidity,
likely because it absorbed so much water. Lin et al25 argued
that transparent ﬁlms need not necessarily be associated with
increased infection rates due to low MVTR as previously sug-
gested by others because they can still allow the 1-way release
of moisture, without absorbing ﬂuid. In fact, another study26
looked at the regrowth of the bacterial ﬂora on the skin of
50 human volunteers and 49 hospital inpatients after the skin
was disinfected and covered for 3 days with either gauze or
1 of 3 different transparent ﬁlms to simulate a catheter inser-
tion site. All dressings prevented indigenous ﬂora from return-
ing to the normal population densities seen on uncovered skin,
with no difference between gauze and transparent ﬁlms.
Gallieni27 reviewed additional studies discussing dressing
permeability and risk of infection and concluded that trans-
parent dressings do not appear to cause an increase in infection
rates. Gallieni27 also cited advantages of transparent ﬁlms such
as excellent adhesion, ﬁrm support of the catheter, and cost
savings due to fewer replacements needed.258 j JAVA j Vol 19 No 4 j 20What are the best practices for the care and maintenance of
PIV catheters to reduce the risk of infection?
Various guidance documents have been issued by profes-
sional organizations. The Centers for Disease Control and Pre-
vention has issued guidelines (last updated in 2011) for the
prevention of intravascular catheter-related infections.13 The
guidelines cover peripheral, midline, and central catheters.
They were developed by critical care medicine scientists from
theNational Institutes ofHealth and experts fromvarious profes-
sional organizations and are available online at http://tinyurl.
com/3wpa4ae. These guidelines state that 250,000 catheter-
related BSIs occur annually in US hospitals, and that 80,000
(32%) of them occur in intensive care units. Regarding speciﬁc
recommendations for PIV catheters, the guidelines recommend
hand hygiene and aseptic technique to insert catheters, and to
prepare clean skin with an antiseptic before PIV catheter inser-
tion. These guidelines state that a gauze dressing or a transparent
ﬁlm dressing can be used, which should be changed if the dres-
sing becomes damp, loosened, or visibly soiled. The guidelines
then state that “Transparent, semi-permeable polyurethane
dressings permit continuous visual inspection of the catheter
site and require less frequent changes than do standard gauze
and tape dressings,”13 and that the site should be evaluated daily
(palpation if opaque dressing is used, and inspection if a trans-
parent dressing is used).
The Infusion Nurses Society recommends18 the following
practice for vascular access device site care and dressing
changes: skin antisepsis should be performed using a chlorhex-
idine solution as the preferred product except for in infants
younger than age 2 months (1% or 2% povidone-iodine and
70% alcohol may also be used). Following the insertion of
the vascular access device, a sterile dressing should be applied
and maintained, and changed when soiled or no longer intact.
The Infusion Nurses Society speciﬁes that the site care fre-
quency is based on type of dressing: Transparent semiperme-
able dressings should be changed every 5-7 days and gauze
dressings should be changed every 2 days.
Countries other than the United States have also issued
guidelines to prevent infections associated with the use of cath-
eters. Colombian clinical practice guidelines were published in
201028 and include a section on intravascular devices that
states that semipermeable, polyurethane transparent dressings
are preferred over the use of conventional sterile gauze and
tape for the care of catheter insertion sites. The Indian Society
of Critical Care Medicine published their recommendations in
2013.29 They reviewed the Centers for Disease Control and
Prevention guidelines13 and the guidelines of the UK Infection
Control Society30 and presented India-speciﬁc recommenda-
tions that include using either sterile gauze or sterile trans-
parent dressing at the catheter site and keeping the dressings
on for the duration of the catheter, unless they are soiled, loos-
ened, or moist. The most recent guidelines were published in
January 2014 and come from the United Kingdom. Epic39 rec-
ommends the use of a sterile, transparent, semipermeable poly-
urethane dressing to cover the insertion site changed every
7 days or sooner if it is no longer intact or if moisture collects
under the dressing. This guideline adds to use a sterile gauze14
Figure 2. Epidermal stripping at the site of a pe-
ripheral venous catheter inserted into a superfi-
cial chest vein.  3M 2011. All rights reserved.dressing if a patient has profuse perspiration or if the site is
bleeding or leaking, and to replace it with a transparent semi-
permeable dressing as soon as possible.9
Today’s health care environment is experiencing more cost
constraints than ever before. For this reasonwe are offering a brief
cost example to compare transparent ﬁlms to gauze and tape.
Information obtained from a hospital in South America (Adriana
Padilla Leal, personal communication, 2012) indicates that their
practice consists in changing intravenous access site dressings
daily if using gauze and tape, every 72 hours if using transparent
ﬁlm dressings, and every 96 hours if using advanced securement
dressings such as a bordered ﬁlm as depicted in Figure 1C.
Including the cost of the dressingmaterials at the time of insertion,
this institution in South America calculated that for a 72-hour
period, it costs $4.30 to use gauze and tape, $3.38 to use trans-
parent ﬁlm dressings, and $2.22 to use advanced securement
dressings on a peripheral intravenous access site. This example
shows that although the unit cost of gauze and tape may be lower,
the increased frequency of change makes it a more costly alterna-
tive when taking into consideration the cost of the other materials
required at each dressing change (eg, gloves, antiseptic, alcohol
wipes, hand hygiene, and saline solution) and the labor cost.
Actual costs will vary by country, by location, by speciﬁc brands
used, and based on contracts, but the same trends are likely to hold
true.
Does securement matter?
Transparent ﬁlms are generally recognized as also providing
some beneﬁts for the securement of catheters over tape and
gauze. General considerations on the securement and dressing
of vascular access devices are discussed by Gabriel.31 A study
of a pediatric population32 compared a combination transparent
ﬁlm/soft cloth surgical tape dressing to adhesive tape and re-
ported better dressing condition and better securement of the
catheter in the transparent ﬁlm group. A different study33
showed lower dislodgment rates for PIV catheters covered
with transparent dressings compared with gauze. Patient com-
fort, vascular access device stability, and ease of use are factors
that also matter because problems such as skin stripping from
frequent dressing changes are not only painful for patients but
can also contribute to the risk of infection. The topic of skin dam-
age associated with intravenous therapy was reviewed by
Thayer.34 Because gauze and tape dressings must be changed
every 2 days, whereas transparent ﬁlms can stay in place for
up to 7 days, ﬁlms are likely to cause less skin damage. The fre-
quency of dressing change that accompanies the use of gauze
and tape is also associated with the need to prepare skin each
time a dressing is changed, and the use of antiseptic agents
(which are irritants on their own) on skin that may be rendered
more fragile by tape stripping contributes to additional skin dam-
age. An example of this is illustrated in Figure 2. In addition,
transparent ﬁlms allow for daily observation as recommended
by current guidelines without a need for a daily dressing change.
Conclusions
PIV catheters are among the most frequently used medical
devices. The most recently published guidelines9 favor the2014use of transparent ﬁlms over gauze and tape for the care of
PIV catheter sites, unless excessive moisture is present. In
such a case the guidelines advocate the use of a sterile gauze
dressing to handle the ﬂuid but also state to replace it with a
transparent ﬁlm as soon as possible. Of course cost consider-
ations are also important, so the following list presents an
approach from lowest cost to most advanced beneﬁts for the
care of PIV catheter insertion sites.
d Sterile gauze and tape have historically been considered
adequate and comparable to transparent ﬁlms until the
most recent guidelines published in January 2014,35
which favor transparent ﬁlms. The gauze and tape solu-
tion is often perceived as the least expensive option but
in fact this is not the case anymore if the therapy is
needed for >3 days.35 This was conﬁrmed by cost data
provided to us by a hospital facility in South America.
In addition, gauze may be sterile coming out of its pack-
age but it does not provide a barrier and it can be easily
contaminated over time in the environment. Another fac-
tor that is important to consider is the fact that potential
microorganisms carried by reused rolls of tape needed to
attach the gauze19 may compromise the sterility of these
dressings.
d Transparent ﬁlm dressings offer the advantage of allow-
ing daily inspection (as recommended in all guidelines)
without dressing removal, and they offer a barrier to air
contaminants and external pathogens. Reducing the num-
ber of dressing changes preserves skin integrity and
therefore lowers the risk of trauma and infection. More-
over, skin prepping is needed at each dressing change
and besides the additional time and cost incurred with
this step, the repeated use of prepping solutions can
contribute to skin irritation, especially when the skin is
rendered more fragile by frequent tape removal. Patient
comfort is also increased when less-frequent dressing
changes are needed. Because the newest guidelines9
advocate clinically indicated replacement of PIVj Vol 19 No 4 j JAVA j 259
catheters instead of routine replacement, these dressings
will perform better than gauze and tape for longer dura-
tions between catheter changes. This type of dressing is
the favored option for PIV catheter sites in the most cur-
rent guidelines.9
d Transparent ﬁlm dressings with additional securement fea-
tures can provide better stability and reduce complica-
tions.36 Some bordered ﬁlm dressings have also been
purposely designed to be used with speciﬁc catheters,
ensuring that the products work well together as intended.37
d A newer type of transparent ﬁlm dressing is now avail-
able with a chlorhexidine gluconate-impregnated gel
patch to provide ongoing disinfection of the site
throughout the duration of the catheter and has been
shown to decrease by 60% the risk of catheter-related
BSI in an intensive care unit in a study on central cathe-
ters.38 The beneﬁts would be likely to apply to PIV cath-
eter sites as well, although this has not been studied yet.
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